• CDC42 Polarity Control Shapes Intestinal Stem Cell Fate via

  2026-04-30

  Zhang et al. reveal that CDC42-dependent epithelial polarity critically determines the balance between intestinal stem cells and transit amplifying cells through a Hippo-YAP-EGF-mTOR signaling cascade. These findings reframe our understanding of stem cell niche regulation, offering new perspectives for research on gastrointestinal epithelial homeostasis and disease mechanisms.

• Estradiol Benzoate: Molecular Precision in Estrogen Receptor

  2026-04-30

  Explore Estradiol Benzoate as a high-affinity estrogen receptor alpha agonist for advanced hormone receptor signaling research. This article uniquely bridges structural, biophysical, and assay design insights to elevate your experimental strategies.

• Adipose-Neural Axis in Cardiac Arrhythmias: NPY and Leptin a

  2026-04-29

  Fan et al. (2024) reveal how epicardial adipose tissue (EAT) interacts with the sympathetic nervous system to promote cardiac arrhythmias, highlighting leptin and neuropeptide Y (NPY)/Y1R signaling as critical mediators. Their stem cell-based coculture model demonstrates mechanistic links and intervention points, advancing the understanding of arrhythmogenesis and opening new research directions.

• Nonconventional GLP-1 and Glucagon Receptor Crosstalk Unveil

  2026-04-29

  Chepurny et al. (2019) reveal that glucagon can act as a nonconventional agonist at the GLP-1 receptor, challenging the dogma of strict ligand-receptor specificity in metabolic GPCR signaling. High-throughput FRET assays for cAMP illuminate the complex interplay and promiscuity among GLP-1 and glucagon receptor agonists and antagonists, with broad implications for interpreting metabolic regulation studies and designing peptide-based therapeutics.

• Myriocin: Serine Palmitoyltransferase Inhibitor in Metabolic

  2026-04-28

  Myriocin is a potent serine palmitoyltransferase inhibitor central to sphingolipid metabolism research. Evidence shows it modulates lipid and glucose homeostasis and inhibits cancer cell proliferation. Its high selectivity and reproducibility make it a benchmark tool for oncology and metabolic disorder studies.

• Tigecycline (SKU A5226): Reliable Solutions for MDR Bacteria

  2026-04-28

  This article delivers evidence-based guidance for researchers using Tigecycline (SKU A5226) in cell-based assays targeting multidrug-resistant bacteria. Through scenario-driven Q&A and literature-backed best practices, we address experimental challenges and show how this glycylcycline antibiotic from APExBIO supports reproducibility and robust data generation.

• (S)-(+)-Dimethindene maleate: Practical M2 Antagonist Guide

  2026-04-27

  (S)-(+)-Dimethindene maleate addresses the need for selective M2 muscarinic receptor antagonism in studies of autonomic and cardiovascular regulation. It is intended for precise receptor pathway interrogation in in vitro and ex vivo research; use outside of validated pharmacological workflows or for diagnostic/medical purposes is not supported.

• CLCC1-Mediated Membrane Fusion in Herpesvirus Nuclear Egress

  2026-04-27

  This study identifies the host chloride channel CLCC1 as a critical mediator of membrane fusion during herpesvirus nuclear egress, resolving a longstanding gap in understanding how large viral capsids exit the nucleus. The findings reveal an ancient, conserved mechanism of nuclear envelope morphogenesis and open new avenues for dissecting host–virus interactions and membrane fusion biology.

• Toremifene Citrate in Systems Biology: Quantitative ER Modul

  2026-04-26

  Explore how Toremifene Citrate, an oral selective estrogen receptor modulator, empowers integrative systems biology and quantitative breast cancer research. Discover advanced assay strategies, protocol parameters, and insights to optimize estrogen receptor signaling studies.

• AMPK’s Dual Role in Autophagy: Suppression and Preservation

  2026-04-25

  This study overturns the prevailing model of AMPK as a direct inducer of autophagy under glucose starvation. Instead, it demonstrates that AMPK suppresses ULK1-mediated autophagy initiation yet preserves the autophagy machinery, offering a nuanced understanding of energy stress responses and autophagy regulation.

• BIRB 796 (Doramapimod): Precision p38α MAPK Inhibition in In

  2026-04-24

  BIRB 796 (Doramapimod) from APExBIO sets the benchmark for selective p38α MAPK inhibition, enabling reproducible results in inflammation and apoptosis assays. Discover workflow optimizations, troubleshooting strategies, and dual-action insights that set this inhibitor apart for advanced cellular signaling research.

• EZ Cap™ Firefly Luciferase mRNA: Advancing Bioluminescent Re

  2026-04-24

  Explore the scientific innovations of EZ Cap™ Firefly Luciferase mRNA, a leading bioluminescent reporter with Cap 1 structure. This article delivers actionable insights for optimizing mRNA delivery and translational assays, grounded in new research on lipid nanoparticle design.

• Targeting Cell Surface NPM1 in AML: A New Therapeutic Antige

  2026-04-23

  This study reveals nucleophosmin (NPM1) as a novel, tumor-selective cell surface protein in acute myeloid leukemia (AML), demonstrating its potential as a generalizable therapeutic target. The researchers developed a monoclonal antibody against cell surface NPM1, achieving effective tumor control in preclinical models without toxicity, thus expanding the toolkit for precise AML immunotherapy.

• BFH772 (VEGFR2 inhibitor): Protocols & Practical Use in Rese

  2026-04-23

  BFH772 is a highly selective small-molecule VEGFR2 inhibitor designed for targeted disruption of VEGFR2-mediated angiogenic signaling. It is best used in tumor angiogenesis and VEGFR2 pathway research requiring precise modulation of kinase activity. BFH772 should not be applied in workflows needing water-soluble compounds or where broad-spectrum kinase inhibition is required.

• YTHDF2 Inhibition Boosts Hippocampal Memory via m6A mRNA Reg

  2026-04-22

  This study reveals that inhibiting YTHDF2, a key m6A reader protein, enhances protein synthesis and hippocampus-dependent memory by reducing m6A-mediated mRNA degradation in neurons. These findings clarify a specific epitranscriptomic mechanism underlying synaptic plasticity and memory, with implications for designing molecular interventions in cognitive research.

16367 records 1/1092 page Next 12345 下5页 Last page